Skip to main content

Advertisement

Log in

The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy

  • Breast
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate whether magnetic resonance (MR) imaging features can predict the presence of occult invasion in cases of biopsy-proven pure ductal carcinoma in situ (DCIS).

Methods

We retrospectively reviewed 92 biopsy-proven pure DCIS in 92 women who underwent MR imaging. The following MR imaging findings were compared between confirmed DCIS and invasive breast cancer (IBC): lesion size, type, morphological and kinetic assessments by ACR BI-RADS MRI, and findings of fat-suppressed T2-weighted (FS-T2W) imaging.

Results

Sixty-eight of 92 (74%) were non-mass-like enhancements (NMLE) and 24 were mass lesions on MR imaging. Twenty-one of 68 (31%) NMLE and 13 of 24 (54%) mass lesions were confirmed as IBC. In NMLE lesions, large lesions (P = 0.007) and higher signal intensities (SI) on FS-T2W images (P = 0.032) were significantly associated with IBC. Lesion size remained a significant independent predictor of invasion in multivariate analysis (P = 0.032), and combined with FS-T2W SIs showed slightly higher observer performances (area under the curve, AUC, 0.71) than lesion size alone (AUC 0.68). There were no useful findings that enabled the differentiation of mass-type lesions.

Conclusions

Breast MR imaging is potentially useful to predict the presence of occult invasion in biopsy-proven DCIS with NMLE.

Key Points

  • MR mammography permits more precise lesion assessment including ductal carcinoma in situ

  • A correct diagnosis of occult invasion before treatment is important for clinicians

  • This study showed the potential of MR mammography to diagnose occult invasion

  • Treatment and/or aggressive biopsy can be given with greater confidence

  • MR mammography can lead to more appropriate management of patients

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Renshaw AA (2002) Predicting invasion in the excision specimen from core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med 126:39–41

    PubMed  Google Scholar 

  2. Jackman RJ, Burbank F, Parker SH (2001) Stereotactic breast biopsy of non palpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 218:497–502

    PubMed  CAS  Google Scholar 

  3. Lagios MD, Westdahl PR, Margolin FR, Rose MR (1982) Duct carcinoma in situ. Relationship if extent of non-invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short term treatment failures. Cancer 50:1309–1314

    Article  PubMed  CAS  Google Scholar 

  4. Lee CH, Carter D, Philpotts LE et al (2000) Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology 217:466–470

    PubMed  CAS  Google Scholar 

  5. Bonnett M, Wallis T, Rossmann M et al (2002) Histological and radiological analysis of ductal carcinoma in situ diagnosed stereotactic incisional core breast biopsy. Mod Pathol 15:95–101

    Article  PubMed  Google Scholar 

  6. Hoorntje LE, Schipper ME, Peeters PH et al (2003) The findings of invasive cancer after a preoperative diagnosis of ductal carcinoma in situ: causes of ductal carcinoma in situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 10:748–753

    Article  PubMed  Google Scholar 

  7. Yen TW, Hunt KK, Ross MI et al (2005) Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200:516–526

    Article  PubMed  Google Scholar 

  8. Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD (2005) Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 62:253–257

    Article  PubMed  Google Scholar 

  9. Goyal A, Douglas-Jones A, Monypenny I et al (2006) Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases. Breast Canc Res Treat 98:311–314

    Article  Google Scholar 

  10. Dillon MF, McDermott EW, Quinn CM et al (2006) Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. J Surg Oncol 93:559–563

    Article  PubMed  Google Scholar 

  11. Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E (2006) Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 107:1760–1768

    Article  PubMed  Google Scholar 

  12. American College of Radiology (2003) Breast Imaging Reporting and Data System (BI-RADS)—MRI atlas, 1st edn. American College of Radiology, Reston

    Google Scholar 

  13. Jansen SA, Newstead GM, Abe H et al (2007) Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 245:684–691

    Article  PubMed  Google Scholar 

  14. American College of Radiology (2003) Breast Imaging Reporting and Data System (BI-RADS)—mammography atlas, 4th edn. American College of Radiology, Reston

    Google Scholar 

  15. Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, Wobbes T (2009) Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg 198:262–269

    Article  PubMed  Google Scholar 

  16. Berg WA, Gutierrez L, NessAiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233:830–849

    Article  PubMed  Google Scholar 

  17. Kuhl CK, Schrading S, Bieling HB et al (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370:485–492

    Article  PubMed  Google Scholar 

  18. Rahbar H, Partridge SC, Eby PR et al (2011) Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol 21:2011–2019

    Article  PubMed  Google Scholar 

  19. Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD (2007) BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J 13:545–550

    Article  PubMed  Google Scholar 

  20. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L (2005) Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 11:382–390

    Article  PubMed  Google Scholar 

  21. Kuhl C (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244:356–378

    Article  PubMed  Google Scholar 

  22. Facius M, Renz DM, Neubauer H et al (2007) Characteristics of ductal carcinoma in situ in magnetic resonance imaging. Clin Imag 31:394–400

    Article  Google Scholar 

  23. Kuhl C (2006) Concepts for differectial diagnosis in breast MR imaging. Magn Reson Imag Clin N Am 14:305–328

    Article  Google Scholar 

  24. Yuen S, Uematsu T, Masako K, Uchida Y, Nishimura T (2008) Segmental enhancement on breast MR images: differential diagnosis and diagnostic strategy. Eur Radiol 18:2067–2075

    Article  PubMed  Google Scholar 

  25. Yuen S, Uematsu T, Kasami M, Tanaka K, Kimura K, Sanuki J, Uchida Y, Furukawa H (2007) Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis. J Magn Reson Imaging 25:502–510

    Article  PubMed  Google Scholar 

  26. Stomper PC, Geradts J, Edge SB, Levine EG (2003) Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. Am J Roentgenol 181:1679–1684

    Google Scholar 

  27. Uematsu T, Yuen S, Kasami M, Uchida Y (2008) Comparison of magnetic resonance imaging, multidetector row computed tomography, ultrasonography, and mammography for tumour extension of breast cancer. Breast Canc Res Treat 112:461–474

    Article  Google Scholar 

  28. Marcotte-Bloch C, Balu-Maestro C, Chamorey E, Ettore F, Raoust I, Flipo B, Chapellier C (2011) MRI for the size assessment of pure ductal carcinoma in situ (DCIS): a prospective study of 33 patients. Eur J Radiol 77:462–467

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mariko Goto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goto, M., Yuen, S., Akazawa, K. et al. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. Eur Radiol 22, 1255–1264 (2012). https://doi.org/10.1007/s00330-011-2357-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-011-2357-2

Keywords

Navigation